Teladoc Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Revenue	2,602	2,407	2,033	1,094	553.31	Upgrade
Revenue Growth (YoY)	8.13%	18.41%	85.81%	97.71%	32.40%	Upgrade
Cost of Revenue	760.03	743.99	650.26	390.83	184.47	Upgrade
Gross Profit	1,842	1,663	1,382	703.13	368.84	Upgrade
Selling, General & Admin	1,367	1,301	1,105	886.88	339.07	Upgrade
Research & Development	348.52	333.63	311.88	164.94	64.64	Upgrade
Other Operating Expenses	375.12	13,682	230.88	157.73	45.57	Upgrade
Operating Expenses	2,091	15,316	1,648	1,210	449.28	Upgrade
Operating Income	-248.55	-13,653.21	-265.63	-506.42	-80.44	Upgrade
Interest Expense / Income	22.28	21.94	81.14	59.95	29.36	Upgrade
Other Expense / Income	-51.23	-11.82	37.88	9.62	-0.34	Upgrade
Pretax Income	-219.61	-13,663.34	-384.66	-575.99	-109.46	Upgrade
Income Tax	0.76	-3.81	44.14	-90.86	-10.59	Upgrade
Net Income	-220.37	-13,659.53	-428.79	-485.14	-98.86	Upgrade
Shares Outstanding (Basic)	165	161	157	91	72	Upgrade
Shares Outstanding (Diluted)	165	161	157	91	72	Upgrade
Shares Change	1.93%	2.88%	73.40%	25.98%	9.11%	Upgrade
EPS (Basic)	-1.34	-84.60	-2.73	-5.36	-1.38	Upgrade
EPS (Diluted)	-1.34	-84.60	-2.73	-5.36	-1.38	Upgrade
Free Cash Flow	193.67	16.53	130.06	-79.55	18.97	Upgrade
Free Cash Flow Per Share	1.18	0.10	0.83	-0.88	0.26	Upgrade
Gross Margin	70.80%	69.09%	68.01%	64.27%	66.66%	Upgrade
Operating Margin	-9.55%	-567.27%	-13.07%	-46.29%	-14.54%	Upgrade
Profit Margin	-8.47%	-567.53%	-21.09%	-44.35%	-17.87%	Upgrade
Free Cash Flow Margin	7.44%	0.69%	6.40%	-7.27%	3.43%	Upgrade
EBITDA	154	-13,370.76	-83.89	-437.96	-35.15	Upgrade
EBITDA Margin	5.92%	-555.53%	-4.13%	-40.03%	-6.35%	Upgrade
Depreciation & Amortization	351.32	270.64	219.62	78.09	44.95	Upgrade
EBIT	-197.33	-13,641.4	-303.52	-516.04	-80.1	Upgrade
EBIT Margin	-7.58%	-566.78%	-14.93%	-47.17%	-14.48%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).